• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Vanos (fluocinonide) cream

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2010


Summary View




  • In addition, use of Vanos Cream for longer than 2 weeks may also suppress the immune system. 
Carcinogenesis, Mutagenesis, and Impairment of Fertility 
  • Long-term animal studies have not been performed to evaluate the carcinogenic potential of Vanos Cream because of severe immunosuppression induced in a 13-week dermal rat study. The effects of fluocinonide on fertility have not been evaluated.